尖吻蝮蛇毒内一种新抗凝血因子ACFⅡ的纯化及特性

利用阴离子交换层析、凝胶过滤及阳离子交换层析三步方法,从皖南尖吻蝮蛇毒中分离纯化到一个新的抗凝血因子ＡＣＦⅡ（ａｎｔｉｃｏａｇｕｌａｔｉｏｎ ｆａｃｔｏｒⅡ）。纯化的ＡＣＦⅡ在ＰＡＧＥ、ＳＤＳ－ＰＡＧＥ和ＩＥＦ－ＰＡＧＥ图谱上均呈单一区带。ＡＣＦⅡ由两条分子量为１４．６ｋＤ的肽链通过二硫键连接在一起,其等电点为７．０。ＡＣＦⅡ具有显著的抗凝血活性,在体外延长ＰＰＴ时间的最终浓度为０．４ｍｇ／Ｌ。Ａ     

圆弧青霉碱性脂肪酶的分离纯化和特性

圆弧青霉突变株ＰＧ３７ 发酵液经离心、硫酸铵盐析、疏水层析、阴离子交换层析和凝胶过滤分离纯化得到了比活性为每毫克蛋白质５ ２００ ｕ 的碱性脂肪酶, 纯化倍数１６ ．５ , 得率３３．２％ , 在聚丙烯酰胺凝胶电泳（ＰＡＧＥ）和ＳＤＳ聚丙烯酰胺凝胶电泳（ＳＤＳＰＡＧＥ）上均呈现单一蛋白质条带。ＳＤＳＰＡＧＥ 和凝胶过滤分别测得酶的分子量为２７．５ ｋＤ和２９ ｋＤ, 表明该酶以单体形式存在。Ｎ末端１０ 个氨基酸的序列测定结果为ＡＴＡＤＡＡＡＦＰＤ, 与已知的碱性脂肪酶的Ｎ 末端序列没有同源性。酶学特性研究结果表明, 该酶的最适作用温度为２５ ℃, 在３０ ℃以下稳定,４０ ℃处理２０ ｍｉｎ 仅残留３０ ％ 酶活性;ｐＨ 稳定范围在６．５～１０．５ , 最适ｐＨ 为１０ ．０ 。低浓度的碱性蛋白酶对ＰＧ３７ 碱性脂肪酶活性的影响较小, 可同时添加在洗涤剂中。     

杜仲皮中抗真菌蛋白的分离和特性研究

从杜仲（ＥｕｃｏｍｍｉａｕｌｍｏｉｄｅｓＯｌｉｖ）皮中分离纯化到一种新的抗真菌蛋白（ＥｕｃｏｍｍｉａＡｎｔｉｆｕｎｇａｌＰｒｏｔｅｉｎ）,简称ＥＡＦＰ。将切碎的杜仲树皮用ＮａＣｌ溶液在组织捣碎器中高速匀浆提取,经硫酸铁沉淀、ＣＭ一ｃｅｌｌｕｌｏｓｅ离子交换层析和Ｂｉｏ一ｇｅｌ一ｐ一１０凝胶层析纯化。如此纯化而得的ＥＡＦＰ在ＳＤＳ－ＰＡＧＥ胶片上显示一条分子量为５．０ｋＤ的单一带。反相ＨＰＬＣ显示４样品是纯的。等电聚焦电泳测得其ｐＩ值大于１１．０。经还原和氨酰羧甲基化处理,用ＨＰＬＣ层析证明ＥＡＦＰ为单链。用酚一硫酸法未测出其含糖。ＥＡＦＰ是简单单链蛋白。氨基酸组成分析结果表明它宫含Ａｒｇ、Ｃｙｓ和Ｇｌｙ,不含Ｍｅｔ,Ｌｙｓ,Ｔｒｐ,Ｈｉｓ和Ｐｈｅ。未经热变性或ＳＤＳ处理的ＥＡＦＰ与考马氏亮蓝试剂不发生显色反应。手工Ｅｄｍａｎ降解法测得Ｎ一端３个氨基酸残基的顺序为Ｇｌｙ一Ａｓｐ一Ａｌａ。用羧肽酶Ａ和Ｂ酶解ＥＡＦＰ测得其Ｃ一末端为Ｖａｌ．０．３ｍｇ／ｍＬ蛋白明显抑制木霉、小麦赤霉菌、烟草黑茎病菌和棉花枯萎病菌菌丝的生长。蛋白在沸水中保温３０ｍｉｎ活性不变。     

甲基单胞菌Methylomonas sp.GYJ3中甲烷单加氧酶羟基化酶组分…

从Ｍｅｔｈ ｙｌｏｍｏｎａｓ ｓｐ．ＧＹＪ３菌株中经ＤＮＥＡＥ－ＳｅｐｈａｒｏｓｅＣｌ－６Ｂ阴离子交换层析和ＳｅｐｈａｃｒｙｌＳ３００凝胶层析分离出纯化出甲烷加氧酶羟基酶组分,经ＨＰＬＣ分析,纯度大于９０％,分子量为２４０ｋＤ,纯化们数为３．９,比活为２２５ｎｍｏｌ环氧丙烷每分钟毫克蛋白,ＳＤＳ－ＰＡＧＥ表明,羟基化酶由三个亚基组成,亚基分子量为５６、４３、２７ｋＤ．ＩＣＰＡＥＳ测定羟基化酶的Ｆｅ     

酵母菌SH2发酵产物增强干扰素抗病毒活性及其有效成分的初步研究

酵母菌 Ｓ Ｈ２ 发酵产物（ 简称 Ｆ Ｓ Ｈ２） ,用 Ｓｅｐｈａｄｅｘ Ｇ７５ 凝胶层析和 Ｈ Ｐ Ｌ Ｃ 色谱层析分离纯化,收集到一组蛋白。该组蛋白在 Ｐ Ａ Ｇ Ｅ 和 Ｓ Ｄ Ｓ Ｐ Ａ Ｇ Ｅ 电泳上带型一致,无蛋白亚基,分子量范围为５２ ～７２ ｋ Ｄ。凝胶上糖蛋白的特异性染色——— Ｓｃｈｉｆｆ’ｓ 染色显示阳性染色带;用 Ｌｏｗｒｙ’ｓ 法测蛋白和硫酸酚法测糖,显示蛋白与糖的比例约为３∶１ 。该组蛋白与人α干扰素作用,增强干扰素生物学效价分别为１ ．６ ～２ ．８ 倍和１ ．４ ～４ ．０ 倍;经 Ｓｅｐｈａｄｅｘ Ｇ７５ 凝胶层析的 Ｆ Ｓ Ｈ２ 蛋白洗脱峰增效２ ．０１ ～５ ．６８ 倍;发酵液增效１ ．６４ ～６ ．８６ 倍。并证实酵母菌 Ｓ Ｈ２ 增效干扰素的活性成分为５２ ～７２ｋ Ｄ 分子量范围的胞外糖蛋白（ 简称 Ｙ Ｅ Ｇ Ｐｓ） 。     

编码Synechococcus sp. PCC 7002 FNR 中FNR区的基因克隆及其在大肠杆菌中的表达

用ＰＣＲ的方法克隆出了编码蓝细菌Ｓｙｎｅｃｈｏｃｏｃｃｕｓｓｐ．ＰＣＣ７００２ＦＮＲ中ＦＮＲ区的基因ｐｅｔＨＬ,克隆到达载体ｐＥＴ３ａ上,转化大肠杆菌ＢＬ２１（ＤＥ３）后实现了大量表达。重组ＦＮＲ区（ｒＦＮＲＤ）经ＤＥＡＥＳｅｐｈｄｅｘＡ５０离子交换层析及ＳｅｐｈａｄｅｘＧ１００凝胶层析得到大量的电泳均一的ｒＦＮＲＤ。Ｎ末端氨基酸序列分析表明,表达产物确为ｐｅｔＨＬ所编码。且起始Ｍｅｔ翻译后未被除去。ｒＦＮＲＤ与ｒＦＮＲ的吸收光谱相同,其黄递酶活性的最适ｐＨ和最适温度也相同。ｒＦＮＲＤ能在体外催化电子从Ｐ７００到ＮＡＤＰ＋的传递     

湖南尖吻蝮蛇毒两个出血毒素的纯化和理化性质

经ＳｅｐｈａｄｅｘＧ－７５凝胶过滤,ＱＡＥ－ＳｅｐｈａｄｅｘＡ－５０和ＣＭ－Ｓｅｐｈａｄｅｘ Ｃ－２５离子交换层析的步骤,从湖南产尖吻蝮蛇毒中纯化出两个出血毒素。ＳＤＳ－ＰＡＧＥ测得分子量均为２３．５ｋＤ,ＩＥＦ－ＰＡＧＥ测得等电点分别为５．６和５．２,两者具有相似的氨基酸组成,其中酸性氨基酸分别占２３％和２４％。ＤａＨＴ－１和ＤａＨＴ－２的最小出血剂量（ＭＨＤ）分别为０．５μｇ和０．８μｇ。都具     

土曲霉金色变种AT8951菊粉酶的纯化和性质的研究

土曲霉金色变种ＡＴ８９５１菊粉酶粗酶液经硫酸铵分段沉淀、ＤＥＡＥＣｅｌｕｌｏｓｅＤＥ３２离子交换、超滤、ＳｅｐｈａｄｅｃＧ－１５０凝胶过滤和ＦＰＬＣ,获得两个菊粉酶组分ＥＩ和ＥＩＩ,经分析型ＦＰＬＣ和ＰＡＧＥ鉴定为单一纯和分析纯。ＥＩ分量为６６ＫＤ,适适作用温度和ＰＨ分别５５℃和５．８;ＥＩＩ分子量为５６ＫＤ,最适作用温度为５７℃,最适ＰＨ为６．０。ＥＩ和ＥＩＩ皆为糖蛋白,多糖含量分别为２４．７％     

厚果鸡血藤凝集素的纯化及性质

从厚果鸡血藤（ＭｉｌｅｔｉａｐａｃｈｙｃａｒｐａＢｅｎｔｈ．）的种子中分离纯化出一种具强凝集活性和强促有丝分裂原的凝集素。种子经磨粉、浸取、硫酸铵分级、ＤＥＡＥＳｅｐｈａｒｏｓｅ离子交换和ＳｅｐｈａｄｅｘＧ１００分子筛层析,即可获得在ＰＡＧＥ和ＳＤＳＰＡＧＥ上均呈现单一蛋白染色带的凝集素纯品,分子筛层析测得分子量为４０７００,ＳＤＳＰＡＧＥ测得亚基分子量为１９８００;含有１７８％的中性糖。氨基酸组成分析表明,该凝集素富含Ａｓｐ、Ｇｌｕ、Ｔｈｒ、Ｓｅｒ和Ｌｅｕ,同时含有４个Ｔｒｐ,当凝集素浓度为０．４８μｇ／ｍＬ时,即可凝集兔红细胞;对人Ａ、Ｂ和Ｏ型血细胞都能发生凝集,故无血型专一性;其凝集兔红细胞的凝集活性,不能被常见糖类抑制,但可被甲状腺球蛋白、胃粘蛋白和卵粘蛋白所抑制;其凝集活性强烈地依赖于Ｃａ２＋的存在,但Ｍｇ２＋、Ｍｎ２＋、Ｚｎ２＋对其凝集活性全无促进作用;该凝集素是一种强促有丝分裂原,对人外围血中淋巴细胞的转化率高达８４３％,细胞分裂比率可达７８％。     

甲基单胞菌Methylomonas sp.GYJ3中甲烷单加氧酶还原酶组分的纯化和性质

Ｍｅｔｙｌｏｍｏｎａｓｓｐ．ＧＹＪ３菌的甲烷单加氧酶（ＭＭＯ）粗酶提取液经ＤＥＡＥ－ＳｅｐｈａｒｏｓｅＣＬ－６Ｂ阴离子交换层析、ＳｅｐｈａｄｅｘＧ－１００凝胶过滤层析和ＤＥＡＥ－ＴＳＫｇｅｌＨＰＬＣ分离纯化出ＭＭＯ还原酶组分．经ＨＰＬＣ分析,纯度大于９５％,纯化倍数为４．４,加入至ＭＭＯ羟基化酶和调节蛋白Ｂ的体系中表现比活为２２８ｎｍｏｌ环氧丙烷每分钟毫克蛋白．ＳＤＳ－ＰＡＧＥ电泳表明还原酶由一种亚基组成,分子量４２ｋＤ．ＩＣＰ－ＡＥＳ测定还原酶的Ｆｅ含量为１．８３ｍｏｌＦｅ每ｍｏｌ蛋白．ＵＶ－Ｖｉｓ光谱表明还原酶除２８０ｎｍ蛋白质特征峰外在４６０ｎｍ有最大吸收峰,且Ａ２８０ｎｍ／Ａ４６０ｎｍ为２．５０,与其它黄素一铁硫蛋白相似,推测还原酶可能含一个ＦＡＤ辅基和Ｆｅ２Ｓ２中心．在厌氧条件下,还原酶能够和ＮＡＤＨ作用,ＵＶ－Ｖｉｓ光谱分析表明还原酶４６０ｎｍ处特征吸收峰消失,说明在ＭＭＯ催化过程中还原酶接受ＮＡＤＨ的电子．ＤＥＡＥ－ＳｅｐｈａｒｏｓｅＣＬ－６Ｂ阴离子交换层析分离出调节蛋白Ｂ,部分纯化的调节蛋白Ｂ的分子量大约在２０ｋＤ,它能够提高ＭＭＯ比活性４０倍,ＭＭＯ还原酶和调节蛋白Ｂ单独存在时不具有ＭＭＯ     

蕲蛇蛇毒抗凝血因子的分离纯化与特性

目的 寻找蕲蛇蛇毒中的抗凝血因子。方法 利用硫酸铵沉降、阴离子交换层析、阳离子交换层析及高效液相色谱层析,从蕲蛇蛇毒中分离纯化到一个抗凝血因子。结果 纯化的这一组份在PAGE、SDS—PAGE上均呈单一区带,分子量约为25．4kD,由两条分子量分别为15．0kD和16．0kD的肽链通过二硫键连接在一起。这一组份在体外显著地延长血浆复钙时间和凝血酶原时间,但不延长牛凝血酶时间,也不具有磷脂酶A2活性、纤溶活性和出血活性。结论 蕲蛇蛇毒中舍右一种新的抗凝血因子。     

一种新的烙铁头蛇毒肌肉毒素

用分子筛和快速蛋白质液相色谱从烙铁头（ＴＲｒｉｍｅｒｅｓｕｒｕｓ ｍｕｃｒｏｓｑｕａｍａｔｕｓ）蛇毒中分离了一个新的碱性肌肉毒素,命名为ＴＭＰＢ。它的分子量为１６０００,等电点为９．２．用蛋白质序列仪测定了其Ｎ端２４个氨基酸残基,ＴＭＰＢ与其他两个从同种蛇毒中分离到的碱性磷酯酶Ａ２的同源性分别为４１．７％和５４．２％《     

Biochemical and biological characterization of a dermonecrotic metalloproteinase isolated from Cerastes cerastes snake venom

A dermonecrotic metalloproteinase (CcD‐II) was isolated from C. cerastes venom. Venom fractionation was performed using three chromatographic steps (molecular exclusion on Sephadex G‐75, ion‐exchange on DEAE‐Sephadex A‐50, and reversed‐phase high‐performance liquid chromatography on C8 column). CcD‐II presented an apparent molecular mass of 39.9 kDa and displayed a dermonecrotic activity with a minimal necrotic dose of 0.2 mg/kg body weight. CcD‐II showed proteolytic ability on casein chains and on α and β fibrinogen chains that was inhibited by ethylenediamine tetraacetic acid and 1,10‐phenanthroline while remained unaffected by phenylmethylsulphonyl fluoride and heparin. CcD‐II displayed gelatinase activity and degraded extracellular matrix compounds (type‐IV collagen and laminin). These results correlated with histopathological analysis showing a complete disorganization of collagenous skin fibers. These data suggested that CcD‐II belongs to P‐II class of snake venom metalloproteinase. The characterization of venom compounds involved in tissue damage may contribute in the development of new therapeutic strategies in envenomation.     

Purification and characterization of the anticoagulant principle of Trimeresurus mucrosqualatus venom

By means of CM-Sephadex column chromatography, Trimeresurus mucrosquamatus venom was separated into 20 fractions. Fraction XX had the marked anticoagulant action. This fraction was refractionated three times on Sephadex G-75, and a single peak was obtained. The patterns of microzone and disc electrophoresis also showed a single band. A single, symmetrical boundary with a value of 1.61 S was obtained by ultracentrifugation. It was a single peptide chain with a molecular weight of 11 700. The isoelectric point was higher than pH 10.The anticoagulant principle possesses phospholipase A activity and was calcium ion dependent. It did not possess proteolytic, tosyl-L-arginine methyl ester esterase, phosphodiesterase and alkaline phosphomonoesterase activities of the crude venom. The phospholipase A activity was heat-labile at pH 7.4, but was heat-stable at pH 5.6. The anticoagulant activity was more resistant to heat treatment as compared with phospholipase A activity.The anticoagulant action of the purified principle was competitively inhibited by platelet phospholipid, tissue thromboplastin and cephalin, and was neutralized by antiserum. The anticoaugulant principle inhibited platelet aggregation induced by ADP. It did not destroy fibrinogen, Factor X, prothrombin and thrombin; nor did it induce fibrinolysis nor interfere with the interaction between thrombin and fibrinogen. It is concluded that the anticoagulant action of this phospholipase A was due to the inhibition of the activations of Factors X and II through the activation of the procoagulant activity of phospholipids mediated partly by phospholipid-binding activity of this venom enzyme and partly by its enzymatic hydrolysis of phospholipids.     

苦瓜籽核糖体失活蛋白的理化性质及生物活性

采用硫酸铵分级分离,假配基亲和层析和ＳｅｐｈａｃｒｙｌＳ－１００分子筛层析等方法,从苦瓜籽中获得核糖体失活蛋白（ＲＩＰ）．经ＳＤＳ－ＰＡＧＥ、ＰＡＧＥ、ＩＥＦ和ＰＡＳ方法分析均表明为单一蛋白着色带或单一糖蛋白着色带．根据ＳＤＳ－ＰＡＧＥ和Ｓｅｐｈａｄｅｘ Ｇ－１５０分子筛层析结果计算其相对分子质量为３．０×１０４,经ＩＥＦ－ＰＡＧＥ结果计算其ｐＩ为８．９～９．０．对无细胞系统中蛋白质生物合成抑制活性明显,其ＩＣ５０为５．３×１０－ １０ ｍ ｏｌ／Ｌ左右．体外生物活性试验结果表明其对人肝癌细胞、Ｖｅｒｏ、ＳＰ２／０、３Ｔ３、Ｋｂ、Ｎａｖａｎａ 等肿瘤细胞株均表现有不同程度的抑制作用．而对完整细胞人胚肺二倍体细胞却毒性极小．因此,上述实验结果为该ＲＩＰ的进一步深入研究和有可能开发成免疫毒素的高效弹头药物提供了一定的工作基础．     

Purification and characterization of a neutrophil chemotactic factor from Dirofilaria immitis

A neutrophil chemotactic factor (NCF-Di) was purified from a crude extract of Dirofilaria immitis adult worm by a combination of anion-exchange chromatography on DE52 and gel filtration on Sephacryl S-200. NCF-Di showed a single protein band by both polyacrylamide gel electrophoresis (PAGE) and sodium dodecyl sulfate (SDS) PAGE. The molecular weight of NCF-Di was estimated to be 17,000 by gel filtration on Sephadex G-150, and 14,000 by SDS-PAGE. NCF-Di was an acidic protein with isoelectric point of 4.5. NCF-Di was absorbed neither to lentil lectin-Sepharose nor to concanavalin A-Sepharose. The chemotactic activity of NCF-Di was heat labile (56 C, 1 hr), but was resistant to periodate oxidation. These results suggest that NCF-Di is a simple peptide which has few or no sugar chains. These physicochemical properties of NCF-Di were compared to previously reported parasite-derived chemoattractants or purified allergen of D. immitis.     

Anticoagulant proteases from western diamondback rattlesnake (Crotalus atrox) venom

Crotalus atrox venom contains agents that render human fibrinogen and plasma incoagulable by thrombin. To elucidate the mechanism of alteration of fibrinogen clotting function by the venom, four immunochemically different proteases, I, II, III, and IV, were purified from the venom by anion-exchange chromatography and column gel filtration. All four proteases had anticoagulant activity rendering purified fibrinogen incoagulable. Proteases I and IV do not affect fibrinogen in plasma but in purified fibrinogen cleave the A alpha chain first and then the B beta and gamma chains. Both enzymes are metalloproteases containing a single polypeptide chain with 1 mol of zinc, are inhibited by (ethylenedinitrilo)tetraacetate and human alpha 2-macroglobulin, and have an optimal temperature of 37 degrees C and an optimal pH of 7. Protease I has a molecular weight (Mr) of 20 000 and is the most cationic. Protease IV has an Mr of 46 000 and is the most anionic glycoprotein with one free sulfhydryl group. Proteases II and III degrade both purified fibrinogen and fibrinogen in plasma, cleaving only the B beta chain and leaving the A alpha and gamma chains intact. Both enzymes are alkaline serine proteases, cleave chromogenic substrates at the COOH terminal of arginine or lysine, are inhibited by diisopropyl fluorophosphate and phenylmethanesulfonyl fluoride, and have an optimal temperature of 50-65 degrees C. Protease II is a single polypeptide chain glycoprotein with an Mr of 31 000. Protease III is a two polypeptide chain protein with an Mr of 24 000, each of the two chains having an Mr of 13 000; its activity is not affected by major protease inhibitors of human plasma. Proteases II and III are enzymes with unique and limited substrate specificity by cleaving only the B beta chain, releasing a peptide of Mr 5000 and generating a fibrinogen derivative of Mr 325 000, with intact A alpha and gamma chains and poor coagulability. Since the two enzymes are active in human plasma and serum, it is postulated that proteases II and III can mediate anticoagulant effects in vivo after envenomation.     

眼镜蛇毒纤维蛋白原溶解因子的纯化及理化性质的研究

经Heparin-SepharoseCL-6B亲和层析和SephadexG-150分子筛层析,从中国眼镜蛇毒(Najanajaatra)中纯化出一种可水解纤维蛋白原Aα链的蛋白酶——组分F.SDS-PAGE测得分子量为47100,为一含2%中性己糖的单肽链糖蛋白;它对纤维蛋白、酪蛋白和苯甲酰-L-精氨酸乙酯(BAEE)均无水解作用,也无激活纤溶酶原的作用;100μg皮下或皮内注射,未见出血反应。组分F对酸和热均不稳定。EDTA,EGTA,PMSF和肝素等可抑制其纤维蛋白原溶解活性,benzami-dine,aprotinin和大豆胰蛋白酶抑制因子(SBTI)则无抑制作用。     

Ca(2+) -induced binding of anticoagulation factor II from the venom of Agkistrodon acutus with factor IX

Anticoagulation factor II (ACF II), a coagulation factor X- binding protein from the venom of Agkistrodon acutus has both anticoagulant and hypotensive activities. Previous studies show that ACF II binds specifically with activated factor X (FXa) in a Ca(2+) -dependent manner and inhibits intrinsic coagulation pathway. In this study, the inhibition of extrinsic coagulation pathway by ACF II was measured in vivo by prothrombin time assay and the binding of ACF II to factor IX (FIX) was investigated by native polyacrylamide gel electrophoresis and surface plasmon resonance (SPR). The results indicate that ACF II also inhibits extrinsic coagulation pathway, but does not inhibit thrombin activity. ACF II also binds with FIX with high binding affinity in a Ca(2+) -dependent manner and their maximal binding occurs at about 0.1 mM Ca(2+) . ACF II has similar binding affinity to FIX and FX as determined by SPR. Ca(2+) has a slight effect on the secondary structure of FIX as determined by circular dichroism spectroscopy. Ca(2+) ions are required to maintain in vivo function of FIX Gla domain for its recognition of ACF II. However, Ca(2+) at high concentrations (>0.1 mM) inhibits the binding of ACF II to FIX. Ca(2+) functions as a switch for the binding between ACF II and FIX. ACF II extends activated partial thromboplastin time more strongly than prothrombin time, suggesting that the binding of ACF II with FIX may play a dominant role in the anticoagulation of ACF II in vivo.     

Purification and Some Properties of Acidocin 8912, a Novel Bacteriocin Produced by Lactobacillus acidophilus TK8912

Acidocin 8912, a bacteriocin produced by Lactobacillus acidophilus TK8912, was purified by ammonium sulfate fractionation and successive chromatographies on CM-cellulose, Sephadex G-50, Sephadex G-25, and reversed-phase HPLC on Aquapore RP-300. The purified acidocin 8912 migrated as a single band on SDS–PAGE. The molecular weight was estimated to be 5200 by SDS–PAGE, and 5400 by HPLC gel filtration on TSKgel G3000PW_XL. Both the amino acid composition and the N-terminal amino acid sequence analysis indicated that acidocin 8912 was a peptide composed of presumably 50 amino acids containing a Lys residue at the N-terminus. The purified acidocin 8912 showed a bactericidal effect on sensitive cells but not a bacteriolytic effect.